Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record describes a phase I/II trial of CIMAvax with nivolumab or pembrolizumab for advanced lung or head and neck cancer, including treatment plans, eligibility criteria, locations, and outcome measures. It is listed as active but not recruiting.
    Difference
    75%
    Check dated 2026-11-11T12:15:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The 403 error message and its Home link are no longer displayed; the study-record area appears empty.
    Difference
    0.5%
    Check dated 2026-11-04T12:40:16.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision label advanced from v3.7.1 to v3.7.2. The study-record area still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-21T13:46:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T14:27:23.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, blocking access to the study record. Previous study-related terms and content appear removed or hidden due to the access restriction.
    Difference
    22%
    Check dated 2026-09-23T19:56:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.7.0 has been added, replacing the previous Revision: v3.6.6. The page now reflects the newer revision version.
    Difference
    0.0%
    Check dated 2026-09-16T21:53:28.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.